WebJan 19, 2024 · Dyne was formed in 2024 and went public in 2024, raising net proceeds of $246.4 million at $19 a share. The stock trades near $13.50 a share, translating to a market cap of approximately $700 million. WebJan 27, 2024 · With a market capitalization of US$963m, Dyne Therapeutics is a decent size, so it is probably on the radar of institutional investors. In the chart below, we can see that institutions own shares ...
Dyne Therapeutics - DYN - Stock Price & News The Motley Fool
WebDYN stock forecast Our latest prediction for Dyne Therapeutics Inc's stock price was made on the Dec. 15, 2024 when the stock price was at 13.59$.. In the short term (2weeks), DYN's stock price should underperform the market by -4.52%.During that period the price should oscillate between -12.37% and +6.64%.. In the medium term (3months), DYN's stock … WebApr 11, 2024 · The firm has a market capitalization of $496.90 million, a P/E ratio of -2.72 and a beta of 0.24. Dyne Therapeutics has a 12 month low of $4.30 and a 12 month high of $15.63. clip art of a skeleton
DYN Dyne Therapeutics Inc. Stock Price & News - WSJ
WebYou can buy and sell Dyne Therapeutics (DYN) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. ... Market cap. 628.17M. Market cap 628.17M. Price-Earnings ratio-3.44. WebMar 20, 2024 · Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with … WebDyne Therapeutics (DYN) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... Market Cap. $495.76M. Enterprise Value $263.49M. Total Cash (Recent Filing) $256.01M. Total Debt (Recent Filing) $30.48M. Price to Earnings (P/E)-2.7. Beta 0.93. Next … clip art of asking questions